Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-29

FDA Approved: VUMERITY — Original Application (Biogen Inc.)

View source ↗

Summary

The FDA approved Biogen's VUMERITY (diroximel fumarate) through its original NDA (NDA 211855). This approval supports use of diroximel fumarate for relapsing fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VUMERITY (diroximel fumarate)

Snippet

ORIG AP for VUMERITY (DIROXIMEL FUMARATE)